Alpha 2.0
Login Register
» Articles » PMID: 3768877

Phase II Study of Etoposide for Carcinoma of the Bladder: the Southeastern Cancer Study Group Experience

Overview
Journal Cancer Treat Rep
Specialty Oncology
Date 1986 Nov 1
PMID 3768877
Citations 4
Authors
P J Walther
S D Williams
M Troner
F A Greco
R Birch
L H Einhorn
Affiliations
Soon will be listed here.
Citing Articles

Role of chemotherapy in prostate cancer.

Nader R, El Amm J, Aragon-Ching J Asian J Androl. 2017; 20(3):221-229.

PMID: 29063869 PMC: 5952475. DOI: 10.4103/aja.aja_40_17.

A screening of a library of T7 phage-displayed peptide identifies E2F-4 as an etoposide-binding protein.

Takami M, Takakusagi Y, Kuramochi K, Tsukuda S, Aoki S, Morohashi K Molecules. 2011; 16(5):4278-94.

PMID: 21610657 PMC: 6263361. DOI: 10.3390/molecules16054278.

Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.

Henwood J, Brogden R Drugs. 1990; 39(3):438-90.

PMID: 2184009 DOI: 10.2165/00003495-199039030-00008.

Chemotherapy of advanced transitional-cell carcinoma of the bladder.

Miller R, Torti F Cancer Chemother Pharmacol. 1992; 30 Suppl:S99-110.

PMID: 1394829 DOI: 10.1007/BF00686953.